Innovator股票定義保護主動型ETF-6個月(4月/10月) APOC 深 滬
等待開盤 04-01 09:30:00 美东时间
25.54
-0.265
-1.03%
華盛通- 最 高25.91
- 今 開25.824
- 成交量 7.20万股
- 最 低 25.53
- 昨 收 25.8049
- 總市值 7725.84万
- 52周最高 26.47
- 市盈率 靜 --
- 換手率 2.38%
- 52周最低 24.84
- 委 比 -60.00%
- 總股本 302.50万
- 歷史最高 26.47
- 量 比 8.12
- 振 幅 1.47%
- 歷史最低 24.60
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ROI-US jobs data forces gaze back from Mideast mayhem to AI 'doom': McGeever
ROI-US jobs data forces gaze back from Mideast mayhem to AI 'doom': McGeever The opinions expressed here are those of the author , a columnist for Reuters By Jamie McGeever ORLANDO, Florida, March 5 (Reuters) - With war still raging in the Middle East , investors on Friday will, at least temporarily
03-05 22:00
2026开年中国创新药BD交易刷新阶段新高 瑞博生物大涨超6%
①小核酸药物技术为何近期频繁获得国际制药巨头的高额授权合作？ ②在2026年开年创新药BD交易规模已达332.8亿美元的背景下，合作热潮是否可持续？
02-12 10:13
Arrowhead Pharmaceuticals Launches Phase 1/2a Trial of Dual-Target RNAi Therapy for Mixed Hyperlipidemia
Arrowhead Pharmaceuticals Launches Phase 1/2a Trial of Dual-Target RNAi Therapy for Mixed Hyperlipidemia Arrowhead Pharmaceuticals Inc. has announced the initiation of a Phase 1/2a clinical trial for ARO-DIMER-PA, an investigational RNA interference (RNAi) therapeutic being developed for the treatme
01-28 01:02
Arrowhead Pharmaceuticals Unveils Pipeline Progress and First Commercial Launch in Investor Presentation
Arrowhead Pharmaceuticals Inc. has released a corporate presentation highlighting its recent achievements and future plans. The company reported its first commercial launch in 2025 with REDEMPLO® (plo...
2025-12-08 10:05
